CTCX vs. MGRM, NVNO, NSPR, PDEX, SEPA, LNSR, STIM, CTSO, MODD, and APYX
Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Monogram Orthopaedics (MGRM), enVVeno Medical (NVNO), InspireMD (NSPR), Pro-Dex (PDEX), SEP Acquisition (SEPA), LENSAR (LNSR), Neuronetics (STIM), Cytosorbents (CTSO), Modular Medical (MODD), and Apyx Medical (APYX). These companies are all part of the "surgical & medical instruments" industry.
Monogram Orthopaedics (NASDAQ:MGRM) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.
In the previous week, Monogram Orthopaedics had 1 more articles in the media than Carmell. MarketBeat recorded 3 mentions for Monogram Orthopaedics and 2 mentions for Carmell. Carmell's average media sentiment score of 0.63 beat Monogram Orthopaedics' score of 0.59 indicating that Monogram Orthopaedics is being referred to more favorably in the media.
Monogram Orthopaedics has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.
Monogram Orthopaedics and Carmell both received 0 outperform votes by MarketBeat users.
Monogram Orthopaedics has higher revenue and earnings than Carmell.
Carmell's return on equity of -112.33% beat Monogram Orthopaedics' return on equity.
0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 32.1% of Monogram Orthopaedics shares are owned by insiders. Comparatively, 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Monogram Orthopaedics beats Carmell on 7 of the 9 factors compared between the two stocks.
Get Carmell News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
